tirzepatide semaglutide Shows Superior Weight Loss Over in Phase 3 Trial Addressing the Weight Loss Injectable

Tirzepatides, such as Mounjaro and Zepbound, are technically classified differently because they incorporate agonists of both GLP-1 and another hormone called glucose-dependent insulinotropic polypeptide (GIP)

Results from one study found that semaglutide reduced the risk of major adverse cardiovascular events, including cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke compared to a placebo

The polyphenols in olive oil also show anti-aging promise

Nausea is the most common, affecting up to 60% of people on the highest 12 mg dose in the Phase 2 trial and around 43% in TRIUMPH-4

Consult your Dietician or Health Care Professional before use

Dendritic cells (DCs) DCs are specialized antigen-presenting cells (APCs) that can initiate immune responses and contribute to the development of T cell-mediated immunity